McElhenny Sheffield Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-556
Closed -$22.6K 192
2022
Q4
$22.6K Buy
+556
New +$22.6K 0.01% 248